A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of ACT-1004-1239 in Healthy Male Subjects
Clinical trial NCT03869320 · COMPLETED
Trial details
- NCT number
- NCT03869320
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-25
- Primary completion
- 2019-07-11
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.